Nutrition
Volume 22, Issue 10 , Pages 977-983 , October 2006

Adipose tissue resistin levels in patients with anorexia nervosa

  • Ivana Dostalova, M.Sc.

      Affiliations

    • Institute of Endocrinology, Laboratory of Clinical and Experimental Neuroendocrinology, Prague, Czech Republic
    • Faculty of Sciences, Charles University, Prague, Czech Republic
    • Corresponding Author InformationCorresponding author. Tel.: +420-224-905-266; fax: +420-224-905-325.
    • ,
  • Marie Kunesova, M.D., Ph.D.

      Affiliations

    • Institute of Endocrinology, Laboratory of Clinical and Experimental Neuroendocrinology, Prague, Czech Republic
    • ,
  • Jaroslava Duskova, M.D., Ph.D.

      Affiliations

    • Institute of Pathology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
    • ,
  • Hana Papezova, M.D., Ph.D.

      Affiliations

    • Psychiatric Clinic, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
    • ,
  • Jara Nedvidkova, Ph.D.

      Affiliations

    • Institute of Endocrinology, Laboratory of Clinical and Experimental Neuroendocrinology, Prague, Czech Republic

Received 3 March 2006 ,Accepted 7 June 2006.

References 

  1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307–312
  2. Brichard SM, Delporte ML, Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res. 2003;35:337–342
  3. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002;13:18–23
  4. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174:5789–5795
  5. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003;300:472–476
  6. Nagaev I, Smith U. Insulin resistance and type2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun. 2001;285:561–564
  7. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes. 2001;50:2199–2202
  8. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res. 2002;10:1–5
  9. McTernan PG, McTernan CL, Chetty R, Jenner K, Fischer FM, Lauer MN, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab. 2002;87:2407–2410
  10. Fain JN, Cheema PS, Bahouth SW, Lloyds HM. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun. 2003;300:674–678
  11. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003;149:331–335
  12. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003;88:4848–4856
  13. Chen CC, Li TC, Li CI, Liu CS, Wang HJ, Lin CC. Serum resistin level among healthy subjects: relatioship to anthropometric and metabolic parameters. Metabolism. 2005;54:471–475
  14. Hasegawa G, Ohta M, Ichida Y, Obayashi H, Shigeta M, Yamasaki M, et al. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol. 2005;42:104–109
  15. Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001;276:11252–11256
  16. Valsamikis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, et al. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism. 2004;53:430–434
  17. Wolfe BE, Jimerson DC, Orlova C, Mantzoros CS. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol (Oxf). 2004;61:332–338
  18. Housova J, Anderlova K, Krizova J, Haluzikova D, Kremen J, Kumstyrova T, et al. Serum adiponectin and resistin concentrations in patients with rescrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab. 2005;90:1366–1370
  19. Jove M, Planavila A, Cabrero A, Novell F, Ros E, Zambon D, et al. Reductions in plasma cholesterol levels after fenofibrate treatment are negatively correlated with resistin expression in human adipose tissue. Metabolism. 2003;52:351–355
  20. Huang SW, Seow KM, Ho LT, Chien Y, Chung DY, Chang CL, et al. Resistin mRNA levels are downregulated by estrogen in vivo and in vitro. FEBS Lett. 2005;579:449–454
  21. Ferron F, Considine RV, Peino R, Lado IG, Diaguez C, Casanueva FF. Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa and non-specific eating disorders correlate with the body mass index but are independent of the respective disease. Clin Endocrinol. 1997;46:289–293
  22. Stoving RK, Hangaard J, Hansen-Nord M, Hagen C. A review of endocrine changes in anorexia nervosa. J Psychiatr Res. 1999;33:139–152
  23. Dostalova I, Kopsky V, Duskova J, Papezova H, Pacak K, Nedvidkova J. Leptin concentrations in the abdominal subcutaneous adipose tissue of patients with anorexia nervosa assessed by in vivo microdialysis. Regul Pept. 2005;128:63–68
  24. Hansen TK, Gravholt CH, Orskov H, Rasmussen MH, Christiansen JS, Jorgensen JO. Dose dependency of the pharmacokinetics and acute lipolytic actions of growth hormone. J Clin Endocrinol Metab. 2002;87:4691–4698
  25. Nedvidkova J, Dostalova I, Bartak V, Papezova H, Pacak K. Increased subcutaneous abdominal tissue norepinephrine levels in patients with anorexia nervosa: an in vivo microdialysis study. Physiol Res. 2004;53:409–413
  26. Dostalova I, Pacak K, Nedvidkova J. Application of in vivo microdialysis to measure leptin concentrations in adipose tissue. Int J Biol Macromol. 2003;32:205–208
  27. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed.. Washington, DC: American Psychiatric Association; 1994;
  28. Enoksson S, Nordenstrom J, Bolinder J, Arner P. Influence of local blood flow on glycerol levels in human adipose tissue. Int J Obes Relat Metab Disord. 1995;19:350–354
  29. Lafontan M, Arner P. Application of in situ microdialysis to measure matabolic and vascular response in adipose tissue. Trends Pharmacol Sci. 1996;17:309–313
  30. Matthews DR, Hosker JP, Rudenski AS, Nazlor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cellfunction from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  31. Gerber M, Boettner A, Seidel B, Lammert A, Bar J, Schuster E, et al. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab. 2005;90:4503–4509
  32. Seow KM, Juan CC, Hsu YP, Ho LT, Wang YY, Hwang JL. Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles. Hum Reprod. 2005;20:117–121
  33. Lewandowski KC, Szosland K, O’Callaghan C, Tan BK, Randeva HS, Lewinski A. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices. Mol Genet Metab. 2005;85:61–69
  34. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Waston W, Kerr K, Jones R, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 2003;88:5452–5455
  35. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. Plos Med. 2004;1:e45
  36. Kahl KG, Kruse N, Rieckmann P, Schmidt MH. Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa. Psychoneuroendocrinology. 2004;29:13–20
  37. Brambilla F, Monti D, Franceschi C. Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa. Psychiatry Res. 2001;103:107–114
  38. Nova E, Gomez-Martinez S, Morande G, Marcos A. Cytokine production by blood mononuclear cells from in-patients with anorexia nervosa. Br J Nutr. 2002;88:183–188
  39. Kunnari A, Ukkola O, Paivansalo M, Kesaniemi YA. High plasma resistin level is associated with enhanced hsCRP and leucocytes. J Clin Endocrinol Metab. 2006;91:2755–2760
  40. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111:932–939
  41. Piche ME, Lemieux S, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol. 2005;96:92–97
  42. Komorowska-Pietrzykowska R, Rajewski A, Wiktorowicz K, Sluzewska A. Immunological system activity in anorexia nervosa. Psychiatr Pol. 1996;30:801–810
  43. Cason J, Ainley CC, Wolstencroft RA, Thompson RP. Polymorphonuclear leucocytes in Crohn’s disease and ulcerative proctocolitis: association between enhanced adherence to nylon fibre and disease variables. J Clin Pathol. 1988;41:241–246
  44. Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B, et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord. 2004;28:993–997
  45. Al-Daghri N, Chetty R, McTernan PG, Al-Rubean K, Al-Attas O, Jones AF, et al. Serum resistin is associated with C-reactive protein and LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc Diabetol. 2005;4:10–16

 This study was supported by grant agency GA CR, No. 303/03/0376.

PII: S0899-9007(06)00247-4

doi: 10.1016/j.nut.2006.06.006

Nutrition
Volume 22, Issue 10 , Pages 977-983 , October 2006

Article Tools

* Image Usage & Resolution